028300.KQ

HLB Co., Ltd. [028300.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

028300.KQ Stock Summary

The Moving Average Convergence Divergence (MACD) for 028300.KQ recently turned positive (within last 10 days).

Top 028300.KQ Correlated Resources

028300.KQ

Top 10 Correlated Stocks

028300.KQ

In the News

028300.KQ Financial details

Company Rating

Market Cap

1225.03B

Income

Revenue

Book val./share

Cash/share

Dividend

Dividend %

Employees

162

Optionable

Shortable

Yes

Earnings

21 Feb 2023

P/E

Forward P/E

PEG

P/S

P/B

P/C

P/FCF

Quick Ratio

Current Ratio

Debt / Equity

LT Debt / Equity

EPS (TTM)

EPS next Y

EPS next Q

EPS this Y

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

EPS Q/Q

SMA20

7.8%

SMA50

-15.93%

SMA100

-34.64%

Inst Own

Inst Trans

ROA

ROE

ROC

Gross Margin

Oper. Margin

Profit Margin

Payout

Shs Outstand

39.14M

Shs Float

99.91M

Target Price

52W Range

31000.0-47100.0

52W High

-32.06%

52W Low

+3.23%

RSI

54.58

Rel Volume

0.41

Avg Volume

968.05K

Volume

399.6K

Perf Week

2.73%

Perf Month

2.07%

Perf Quarter

-35.74%

Perf Half Y

-27.52%

Beta

0.403442

Volatility

575.96%, 1270.23%

Prev Close

-0.31%

Price

32000

Change

-0.78%

Something similar

Top by Market Cap

Interesting

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 968.05K
Market Capitalization 1225.03B
Employee 162
CEO Mr. Jung-Min Park
Headquarters Ulsan,KR
IPO Date 2000-02-11
Website https://www.hlbkorea.com

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.